Estrella Immunopharma, Inc. (ESLA)

NASDAQ: ESLA · Real-Time Price · USD

1.840

-0.010 (-0.54%)

At close: Apr 10, 2026, 4:00 PM EDT

1.770

-0.070 (-3.80%)

After-hours: Apr 10, 2026, 7:35 PM EDT

Estrella Immunopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2025	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 10, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023
Market Cap	79	59	43	43	38	39
Market Cap Growth	117.09%	35.65%	-0.01%	13.99%	-2.48%	-3.87%
Enterprise Value	77.55	57.53	41.8	42.52	33.94	39.07
Last Close Price	1.84	1.56	1.15	1.20	1.05	1.11
PE Ratio	-	-4.41	-	-	-3.89	-0.61
PB Ratio	-	-5.68	-4.42	302.18	8.92	-
P/TBV Ratio	-6.56	-5.56	-4.41	302.18	6.66	-
P/FCF Ratio	-	-32.99	-	-5.69	-2.37	-3.39
P/OCF Ratio	-	-32.99	-	-5.69	-2.37	-3.39
EV/EBITDA Ratio	-	-4.40	-	-	-4.64	-13.51
EV/EBIT Ratio	-	-4.40	-	-	-4.64	-13.51
EV/FCF Ratio	-	-32.22	-	-5.57	-2.11	-3.39
Net Debt / Equity Ratio	0.13	0.13	0.17	-6.38	-0.97	-
Net Debt / EBITDA Ratio	0.11	0.11	-	-	0.57	-
Net Debt / FCF Ratio	0.78	0.78	-	0.12	0.26	-
Quick Ratio	0.10	0.10	0.12	0.31	23.05	-
Current Ratio	0.12	0.12	0.15	0.55	24.65	-
Return on Equity (ROE)	255.59%	255.59%	0.00%	0.00%	-342.19%	-81.78%
Return on Assets (ROA)	-413.55%	-413.55%	0.00%	0.00%	-328.31%	-59.90%
Return on Invested Capital (ROIC)	222.88%	222.88%	0.00%	0.00%	-5135.34%	1834.22%
Return on Capital Employed (ROCE)	255.57%	255.57%	0.00%	0.00%	-342.11%	-66.84%
Earnings Yield	-16.55%	-22.66%	0.00%	0.00%	-25.71%	-163.06%
FCF Yield	-	-3.03%	0.00%	-17.59%	-42.17%	-29.54%
Buyback Yield / Dilution	-1.63%	2.14%	-4.34%	-33.54%	-182.63%	-575.48%
Total Shareholder Return	-1.63%	2.14%	-4.34%	-33.54%	-182.63%	-575.48%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q